
Mehran Habibi MD MBA
Breast
Chief of breast surgery at Baptist Health Miami Cancer Institute and Deputy Chief of breast surgery for Baptist Health Cancer Care
Join to View Full Profile
8900 N Kendall DrMiami, FL 33176
Phone+1 786-596-2000
Dr. Habibi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Mehran Habibi, M.D., MBA, is an internationally recognized surgical breast oncologist with over two decades of clinical and academic leadership. He serves as chief of breast surgery at Baptist Health Miami Cancer Institute and deputy chief of breast surgery for Baptist Health Cancer Care. His clinical expertise includes oncoplastic and nipple-sparing mastectomies, nerve-preserving and risk-reducing procedures, and advanced intraoperative tumor localization and margin assessment technologies.
Before joining Baptist Health, Dr. Habibi held senior leadership roles at Northwell Health, including director of breast surgery at Staten Island University Hospital, regional chief of breast surgery for Northwell’s Western Region and director of international program development for Northwell Cancer Institute. He also served as an associate professor of surgery at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Prior to that, he spent more than 15 years at Johns Hopkins University School of Medicine, where he founded and led the Breast Center at the Bayview Medical Center.
Dr. Habibi’s research program spans surgical innovation, genomics and tumor microenvironment studies. His current investigations include wire-free localization techniques, intraoperative margin assessment tools and studies of tumor tissue mechanics, breast cancer genomics, and the role of the microbiome in breast cancer progression and therapy response. His research has been supported by multiple grants and published in high-impact peer-reviewed journals.
Certified by the American Board of Surgery, Dr. Habibi is a fellow of the American Society of Breast Surgeons and a reviewer for The Breast Journal and JAMA Surgery. He is also an editorial board member of Archives of Breast Cancer.
Education & Training
Virginia Commonwealth UniversityMBA, Business Administration, 2007 - 2009
St Luke's University HospitalResidency, Surgery, 2001 - 2005
Azad UniversityClass of 1996
Alborz High SchoolDiploma, Biological Sciences, 1983 - 1987
Certifications & Licensure
FL State Medical License 2025 - 2027
NY State Medical License 2023 - 2027
MD State Medical License 2007 - 2026
CA State Medical License 2014 - 2025
VA State Medical License 2005 - 2008
PA State Medical License 2001 - 2006
American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014-2017
Clinical Trials
- Pre-Operative Radiation and Veliparib for Breast Cancer Start of enrollment: 2013 Jul 22
- Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer Start of enrollment: 2014 Jan 16
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles Start of enrollment: 2017 Apr 28
Publications & Presentations
PubMed
- Rewriting the radiation playbook: NSABP B-51 and the rise of pathologic precision.Mehran Habibi, Bruce G Haffty, Silvia C Formenti
NPJ Breast Cancer. 2025-11-05 - 2 citationsMammaPrint predicts chemotherapy benefit in HR+HER2- early breast cancer: FLEX Registry real-world data.Adam M Brufsky, Kent F Hoskins, Henry J Conter, Pond Kelemen, Mehran Habibi
JNCI Cancer Spectrum. 2025-09-01 - 1 citationsCharacterization of post-mastectomy pain syndrome in breast cancer patients undergoing subsequent reconstruction: A scoping review.Arushi Biswas, Aidan S Weitzner, Lily Zhu, Jeffrey Khong, Shreya Sriram
Journal of Plastic, Reconstructive & Aesthetic Surgery. 2025-08-01
Journal Articles
- Prophylactic Total Gastrectomy for CDH1 Mutation: An Institutional ExperienceSandra R Dibrito, Alex B Blair, Mehran Habibi, Journal of The American College of Surgeons
- CD4+ T cells inhibit the neu-specific CD8+ T-cell exhaustion during the priming phase of immune responses against breast cancerKmieciak M, Worschech A, Nikizad H, gowda M, Habibi M, Depcrynski A, Wang E, godder K, Holt SE, Marincola FM, Manjili MH, Breast Cancer Res Treat, 4/1/2011
- Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor d...Mehran Habibi, MD, Maciej Kmieciak, Laura graham, Johanna K. Morales, Harry D. Bear and Masoud H. Manjili, Breast Cancer Res Treat, 4/1/2009
Authored Content
- Prophylactic Total Gastrectomy for CDH1 Mutation: An Institutional ExperienceOctober 2018
Press Mentions
How Cosmetics and Makeovers Can Help Cancer CareMay 25th, 2021
Cancer Care in the Kingdom of Saudi ArabiaJuly 7th, 2020
Three Weeks, 24 Life-Changing Surgeries at JHAHApril 7th, 2020
Professional Memberships
- Member
Other Languages
- Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









